Author(s)

Joseph L. Blidgen, Clarence D. McGaw

Department of Surgery, Radiology, Anesthesia and Intensive Care, University of the West Indies, Mona P.O., Kingston, Jamaica.

Essential thrombocytosis (ET) is a rare myeloproliferative disorder, which is a major risk factor for thrombosis and bleeding, which complicates cardiovascular surgery. ET is a risk factor for coronary artery disease that should be treated. We present a case of a male with ET who underwent coronary artery bypass grafting (CABG) at the University Hospital of the West Indies, and died post-surgery. Post mortem revealed early graft thrombosis. We believe that post-operative aspirin therapy maybe would have prevented this fatal outcome.

Thrombocytosis, Graft Occlusion, Coronary Artery Bypass Grafting

Blidgen, J. and McGaw, C. (2020) Essential Thrombocytosis and Fatal Coronary Graft Occlusion: A Case Report. World Journal of Cardiovascular Surgery, 10, 187-191. doi: 10.4236/wjcs.2020.1010021.